52125-0833 GARDASIL - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

52125-0833

Brand Name:

GARDASIL

Generic Name:

Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant

Dosage Form Name:

Injection

Administration Route:

Intramuscular

Substances:

Packages:

Code: 52125-0833-01

Description:

Effective Date: Feb. 13, 2014

Discontinued: Feb. 11, 2015

SEER*Rx Category:

Ancillary Therapy

Major Class:

Protective Agent

Minor Class:

HPV Vaccine

Orphan Drug Designation:

Status:

No Longer Used